New combo test may spot hidden heart risk after attack

NCT ID NCT07268391

First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 17 times

Summary

This study looks at whether combining a special CT scan (spectral CT) with a blood test for tiny molecules (miRNAs) can better predict heart damage after a heart attack. About 95 adults who had a severe heart attack will be followed for 6 months. The goal is to create a model that identifies patients at high risk for heart failure, so they can get closer monitoring and personalized treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centro Nacional de Investigaciones Cardiovasculares (CNIC)

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Complejo Asistencial Universitario de Salamanca

    Salamanca, Spain

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clínico Universitario de Valencia

    Valencia, Spain

    Contact Email: •••••@•••••

  • Hospital La Princesa

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Ramón y Cajal

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.